For: | Soni A, Yekula A, Singh Y, Sood N, Dahiya DS, Bansal K, Abraham G. Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis. World J Hepatol 2023; 15(1): 79-88 [PMID: PMC9896500 DOI: 10.4254/wjh.v15.i1.79] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i1/79.htm |
Number | Citing Articles |
1 |
Ahmed Hashim, Ahmed Maraey, Ahmed Elzanaty, Magdi Zordok, Hadeer Elsharnoby, Mahmoud Khalil, Omar Al Wahadneh, Helmy Siragy. Nonalcoholic Fatty Liver Disease Predicts Acute Kidney Injury Readmission in Heart Failure Hospitalizations: A Nationwide Analysis. Current Problems in Cardiology 2023; 48(10): 101816 doi: 10.1016/j.cpcardiol.2023.101816
|
2 |
Leonid Khokhlov, Bekure Siraw, Mehnaaz Ali, Fatima Hussain, Amanda Brown, Kamal Shemisa. Patients with atrial fibrillation and diabetes mellitus affected by nonalcoholic fatty liver disease have a greater risk of mortality and worse clinical outcomes. Cardiovascular Endocrinology & Metabolism 2024; 13(3) doi: 10.1097/XCE.0000000000000307
|
3 |
Tommaso Bucci, Katarzyna Nabrdalik, Francesco Baratta, Daniele Pastori, Pasquale Pignatelli, Theresa Hydes, Uazman Alam, Francesco Violi, Gregory Y H Lip. Risk of Adverse Events in Anticoagulated Patients With Atrial Fibrillation and Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2024; 110(1): 208 doi: 10.1210/clinem/dgae394
|
4 |
Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis, Antonis S. Manolis. Metabolic Dysfunction-Associated Steatotic Liver Disease and the Cardiovascular System. Trends in Cardiovascular Medicine 2025; doi: 10.1016/j.tcm.2025.01.001
|